AzTrials
AzTrials

Intubation ComplicationCRICKETNCT05804188

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation

An observational study of Intubation Complication and Adverse Events, run by Thomas Riva at 8 sites in 5 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The investigators' overall objective is to assess the incidence of critical events related to tracheal intubation at all international study sites. Furthermore, the study will investigate the used intubation techniques and identify possible improvement measures to increase patient safety. Read more about this study

Who is it for?
Ages Up to 16 years
Conditions the study is for
Intubation Complication, Adverse Events
What is being tested?
tracheal intubation
How many people
105,000 participants
Where
8 sitesin 5 countries
Study dates
8 Jan 2024to Jul 2026
How long will I take part?
30 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: All paediatric patients requiring tracheal intubation due to their medical condition are screened if they fulfill the inclusion and exclusion criteria.

Who may be able to join

  • All paediatric patients requiring tracheal intubation, performed by the anaesthesia team for procedures or interventions requiring general anaesthesia
  • Patients from 0 - 16 years of age.
  • Informed or general consent given, according to the relevant ethics committee statement.

Who cannot join

  • Refusal to give consent or withdrawal of consent if such is required by the relevant ethics committee.
  • Patients >16 years

Trial locations and contacts

8 sites in 5 countries. Contact the study team or a site near you to ask about taking part.

Thomas Riva, Prof. Dr. med contact

+41316322111

thomas.riva@insel.ch

Alexander Fuchs, MD contact

+41 31 663 23 84

alexander.fuchs@insel.ch

8 sites in 5 countries

United States2 sites, 2 recruiting
  • Department of Anesthesiology, Critical Care and Pain Medicine

    Boston, Massachusetts, 02115

    John Fiadjoe, Prof.

    Recruiting
  • Dept of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104

    Annery Garcia-Marcinkiewicz, Prof.

    Recruiting

Other trials in United States

Canada2 sites, 2 recruiting
  • Dept. Anesthesia, Montreal Children's Hospital, McGill University Health Centre

    Montreal

    Thomas Engelhardt, Prof.

    Recruiting
  • Dept. Anesthesia, The Hospital for Sick Children

    Toronto, Ontario

    Clyde Matava, Prof.

    Recruiting

Other trials in Canada

Switzerland2 sites, 2 recruiting
  • Unité d'anesthésie pédiatrique, Hôpital des Enfants / HUG

    Geneva, 1205

    Habre Walid, Prof.

    Recruiting
  • Children's Hospital Zurich

    Zurich, 8008

    PD Dr. med. Alexander Schmidt, +41 44 249 7507, Alexander.schmidt@kispi.uzh.ch

    Recruiting

Other trials in Switzerland

Australia1 site, 1 recruiting
  • Department of Anaesthesia and Pain Management, Perth Children's Hospital

    Perth, 6009

    Britta von Ungern-Sternberg, Prof. Dr.

    Recruiting

Other trials in Australia

Germany1 site, 1 recruiting
  • Department of Cardiac Anesthesiology and Intensive Care Medicine, Charité Universitätsmedizin

    Berlin

    Maren Kleine-Brueggeney, Prof. Dr.

    Recruiting

Other trials in Germany

About this study

The investigators' overall objective is to assess the incidence of critical events related to tracheal intubation at all international study sites. Furthermore, the study will investigate the used intubation techniques and identify possible improvement measures to increase patient safety.

Read the detailed description

It is a prospective observational multi-centre study collecting health related patient data over a period of three months. This serves best the study's purpose to detect the incidence and nature of problems related to tracheal intubation and how such problems are handled with the aim to further improve patient safety. During the observational period the anaesthesia staff in charge will complete a screening questionnaire for critical events associated with tracheal intubation for every patient undergoing general anaesthesia with tracheal intubation. If no critical events arise there are no further requirements. If a critical event occurs, the anaesthesia provider will complete a more detailed questionnaire which includes more questions about what exactly happened.

Patient characteristics will be extracted from the anaesthesia records. The investigators will extract such data for all patients undergoing tracheal intubation and additional data for those with critical events. The research will not intervene with the clinical conduct of patient care.

The collected health related data will be transferred to an electronic research data base. In this data base data will be encoded. Every patient with a critical event will be followed up as described above.

Being tested
tracheal intubation
Keywords
Intubation, Intratracheal, Anesthesiology, Difficult Airway, Critical events, Pediatrics

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tracheal intubationOther

    children between 0-16 requiring tracheal intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients with critical events related to intubation

    Primary study outcome is the incidence of anaesthesia cases with critical events associated with endotracheal intubation requiring intervention from the start of anaesthesia until the discharge of the patient from the post-anaesthesia care unit or end of anaesthesia (defined as handover to the paediatric or neonatal intensive care unit, the ward or discharge home straight from anaesthesia care) in children aged 0 - 16 years. Facultatively for those who do not have capacity the acquisition of data stops at the end of anaesthesia (defined as handover to the post-anaesthesia care unit).

    Measured: Maximum of 30 days

Secondary outcomes (13)
  1. Number of patients with severe hypoxemia

    Oxygen saturation (SpO2) < 85% or >20 points below initial value at least 60 seconds

    Measured: 1 hour

  2. Number of patients with severe bradycardia

    0-3 months old: Heart rate (HR) < 80 bpm

    • 4 months - 2 years: HR < 60 bpm
    • 2-10 years old: HR < 40 bpm
    • 10-16 years old: HR < 30 bpm at least 1 minute

    Measured: 1 hour

  3. Number of patients with esophageal intubation

    Tracheal tube placed in the oesophagus diagnosed by (video-) laryngoscopy, absence of sustained end-tidal carbon dioxide (EtCO2) trace, absence of lung ventilation (auscultation or absence of chest excursions) causing a drop in oxygenation

    Measured: 1 hour

  4. Number of patients with laryngospasm

    Complete airway obstruction associated with rigidity of the abdominal and chest walls and leading to unsuccessful child's ventilation, or glottic closure associated with chest movement but silent unsuccessful child's respiratory efforts and assisted ventilation, unrelieved in both situations with simple jaw thrust and continuous positive airway pressure (CPAP) manoeuvres and requiring the administration of medication (propofol, suxamethonium etc.) and/or tracheal (re)-intubation

    Measured: 1 hour

  5. Number of patients with bronchospasm

    Increased respiratory effort, especially during expiration, and wheeze on auscultation. Episode of bronchospasm requires the administration of a bronchodilator.

    Measured: 1 hour

  6. Number of patients with stridor after extubation

    Severe inspiratory flow limitation with sternal retraction, intrathoracic pressure swing, and potentially cyanosis occurring after extubation with or without the administration of oxygen, intravenous steroids and/or epinephrine (nebulization) or tracheal intubation. This can be documented clinically or with diagnostic examination, with persistence of symptoms.

    Measured: 1 hour

  7. Number of patients with obstruction of tracheal tube

    Obstruction of tracheal tube needing lavage or tube exchange

    Measured: 1 hour

  8. Number of patients with airway bleeding

    Acute bleeding from nose, arytenoids or pharynx causing obstruction or risk for pulmonary aspiration

    Measured: 1 hour

  9. Number of patients with can't intubate, can't oxygenate (CICO) situation

    Situation when there is failed intubation and failure to adequately oxygenate using facemask ventilation or supraglottic airway device resulting in increasing hypoxemia in an anaesthetised and paralysed patient

    Measured: 1 hour

  10. Number of patients with severe bradycardia/Cardiac arrest

    Cessation of circulation (no pulse) or severe bradycardia (i.e. fibrillation/tachycardia) requiring chest compressions, during the intubation/extubation manoeuvres.

    Measured: 1 hour

  11. Number of patients with pulmonary aspiration

    Presence of non-respiratory secretions (gastric, particulate, blood) in the airway as evidenced by (video-) laryngoscopy, suctioning, or bronchoscopy or radiologic signs.

    Measured: 1 hour

  12. Number of patients with pneumothorax/ pneumomediastinum

    Air in the thorax and/or mediastinum as consequence of tracheal intubation and ventilation, causing lung collapse or mediastinum dislodgment diagnosed by Lung-ultrasound and/or X-ray.

    Measured: 1 hour

  13. Number of patients with negative pulmonary oedema

    Non-cardiogenic pulmonary oedema that results from the generation of high negative intrathoracic pressure needed to overcome upper airway obstruction.

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2023
  2. Study start8 Jan 2024
  3. Primary completionJun 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
105,000 participants (estimated)
Target duration
30 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT05804188
Sponsor's protocol ID
Cricket 2023
Other IDs
2023-00246, 2023
Acronym
CRICKET
Status last verified
May 2026
First submitted
23 Mar 2023
Last updated
12 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bennett T, Disma N, Engelhardt T, Fiadjoe J, Fuchs A, Garcia-Marcinkiewicz A, Gregori D, Greif R, Habre W, Lorenzoni G, Kleine-Brueggeney M, Matava C, Maria Papappicco CA, Quintao VC, Riva T, von Ungern-Sternberg BS, Zoumenou E. Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation (CRICKET)-study protocol for an international multicentre prospective observational study. BJA Open. 2026 Feb 7;17:100523. doi: 10.1016/j.bjao.2025.100523. eCollection 2026 Mar.

    PubMed 41705042

Questions about this trial

What is this clinical trial studying?

An observational study of Intubation Complication and Adverse Events, run by Thomas Riva at 8 sites in 5 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in United States, Canada, Switzerland, Australia, Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Thomas Riva, Prof. Dr. med (+41316322111, thomas.riva@insel.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients with critical events related to intubation (time frame: Maximum of 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05804188, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in